NCT03835221

Performance of Toric Hydrogel Lenses Following A Refit With Toric Silicone Hydrogel Lenses for 1 Month

Coopervision, Inc.·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov
Study focus
Disease/Condition
Ametropia
Drug/Device/Intervention
methafilcon A toric contact lenses
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Coopervision, Inc.
Location
Mexico City, Mexico
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2019
End date
Jul 06, 2019
Enrollment
43 participants
Primary outcome

Number of Participants With Lens Centration Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Number of Participants With Lens Centration Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Number of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Number of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Number of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Post-blink Movement Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Post-blink Movement Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Post-blink Movement Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Post-blink Movement Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Post-blink Movement Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Lens Orientation in Primary Position of Gaze Assessment by the Investigator - Methalfilcon A Toric Contact Lenses,Lens Orientation in Primary Position of Gaze Assessment by the Investigator - Methalfilcon A Toric Contact Lenses,Lens Orientation in Primary Position of Gaze Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Lens Orientation in Primary Position of Gaze Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Lens Orientation in Primary Position of Gaze Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Rotational Recovery Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Rotational Recovery Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Rotational Recovery Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Rotational Recovery Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Rotational Recovery Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Overall Stability Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Overall Stability Assessment by the Investigator - Methafilcon A Toric Contact Lenses,Overall Stability Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Overall Stability Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Overall Stability Assessment by the Investigator - Fanfilcon A Toric Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Methafilcon A Toric Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Methafilcon A Toric Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Fanfilcon A Toric Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Fanfilcon A Toric Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Fanfilcon A Toric Contact Lenses

Summary

The aim of this prospective study is to evaluate the clinical performance of habitual wearers
 of methafilcon A toric lenses after a refit with fanfilcon A toric lenses for 1-month of
 daily wear.

ICD-10 classifications
Amblyopia ex anopsiaAmoebiasisAmoebiasis, unspecifiedMyoclonusOesophagitis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03835221
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT03835221 through Pure Global AI's free database. This phase not specified trial is sponsored by Coopervision, Inc. and is currently Completed. The study focuses on Ametropia. Target enrollment is 43 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.